Phase 2 Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 12 and 25 years old
- You have been diagnosed with major depression, and that diagnosis was made within the last 12 months, with depression being your most pressing problem needing treatment
- Your depression is at least moderate in severity (as measured by specific rating scales) if you want to take part in the active treatment stage — if your depression scores are lower, you may still be able to take part in follow-up check-ins
- You are able to talk and communicate well enough to take part in talking-based therapy
Who may not be able to join:
- You have a personal history of manic or hypomanic episodes, psychosis, autism spectrum disorder, a developmental disability, an intellectual disability, a mental health condition caused by a neurological or other physical illness, or a current serious substance use problem
- You have previously received any treatment specifically for depression that lasted 4 weeks or longer, or you are currently taking antipsychotic, antidepressant, or mood-stabilising medication
- You have had a change in any mental health medication (including sleep, anxiety, or stimulant medications) in the past 6 weeks, or you have already completed 4 or more sessions of cognitive-behavioural therapy
- You are currently pregnant or breastfeeding (confirm with trial site for further details on how this is handled during the study)
- No one will be turned away based on sex, gender, race, ethnicity, or living situation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rudolf Uher, MD, PhD, Nova Scotia Health Authority
Phone: 902-473-7209
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Severity of depressive symptoms; Severity of depressive symptoms; Proportion of time spent depression free
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.